Teva Pharmaceutical Industries Ltd (TEVJF) Accumulated Expenses (2015 - 2026)
Teva Pharmaceutical Industries' (TEVJF) quarterly Accumulated Expenses came in at $2.7 billion in Q2 2026, down 11.53% YoY from $3.1 billion in Q2 2025, and up 4.66% on a QoQ basis from $2.6 billion in Q1 2026.
Teva Pharmaceutical Industries Ltd (TEVJF) Accumulated Expenses (2015 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVJF) has 12 years of Accumulated Expenses data on file, last reported at $2.7 billion in Q2 2026.
- Quarterly Accumulated Expenses fell 11.53% year-over-year to $2.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 billion (down 11.53% YoY) and the FY2025 annual result came in at $2.7 billion, down 3.76% from the prior year.
- Accumulated Expenses rose to $2.7 billion in Q2 2026, from $2.6 billion in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $3.1 billion in Q2 2025 to a low of $2.0 billion in Q3 2022.
- A 5-year average of $2.6 billion and a median of $2.7 billion in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses surged 40.3% — and 2023, when it decreased 12.71%.
- Tracing TEVJF's Accumulated Expenses over 5 years: stood at $2.2 billion in 2022, then gained by 28.82% to $2.8 billion in 2023, then gained by 0.76% to $2.8 billion in 2024, then slipped by 3.76% to $2.7 billion in 2025, then increased by 1.9% to $2.7 billion in 2026.
- The last three Accumulated Expenses figures came in at $2.7 billion (Q2 2026), $2.6 billion (Q1 2026), and $2.7 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.74 Bn |
| Mar 31, 2026 | 2.62 Bn |
| Dec 31, 2025 | 2.69 Bn |
| Sep 30, 2025 | 2.99 Bn |
| Jun 30, 2025 | 3.10 Bn |
| Mar 31, 2025 | 2.95 Bn |
| Dec 31, 2024 | 2.79 Bn |
| Sep 30, 2024 | 2.98 Bn |
| Jun 30, 2024 | 2.84 Bn |
| Mar 31, 2024 | 2.78 Bn |
| Dec 31, 2023 | 2.77 Bn |
| Sep 30, 2023 | 2.74 Bn |
| Jun 30, 2023 | 2.50 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.15 Bn |
| Sep 30, 2022 | 2.04 Bn |
| Jun 30, 2022 | 2.11 Bn |
| Mar 31, 2022 | 2.60 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Sep 30, 2021 | 2.04 Bn |